These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 29424773)

  • 1. Vaginal microbiota and susceptibility to HIV.
    Eastment MC; McClelland RS
    AIDS; 2018 Mar; 32(6):687-698. PubMed ID: 29424773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Vaginal Microbiome and its Potential to Impact Efficacy of HIV Pre-exposure Prophylaxis for Women.
    Velloza J; Heffron R
    Curr HIV/AIDS Rep; 2017 Oct; 14(5):153-160. PubMed ID: 28812207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal microbiome.
    Buchta V
    Ceska Gynekol; 2018; 83(5):371-379. PubMed ID: 30848142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The vaginal microbiota and susceptibility to HIV.
    Buve A; Jespers V; Crucitti T; Fichorova RN
    AIDS; 2014 Oct; 28(16):2333-44. PubMed ID: 25389548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genital tract and rectal microbiomes: their role in HIV susceptibility and prevention in women.
    Abdool Karim SS; Baxter C; Passmore JS; McKinnon LR; Williams BL
    J Int AIDS Soc; 2019 May; 22(5):e25300. PubMed ID: 31144462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between sex hormones, the vaginal microbiome and immunity in HIV-1 susceptibility in women.
    Wessels JM; Felker AM; Dupont HA; Kaushic C
    Dis Model Mech; 2018 Aug; 11(9):. PubMed ID: 30154116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The microbiome and HIV prevention strategies in women.
    Abdool Karim SS; Passmore JS; Baxter C
    Curr Opin HIV AIDS; 2018 Jan; 13(1):81-87. PubMed ID: 29059077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis.
    Sewankambo N; Gray RH; Wawer MJ; Paxton L; McNaim D; Wabwire-Mangen F; Serwadda D; Li C; Kiwanuka N; Hillier SL; Rabe L; Gaydos CA; Quinn TC; Konde-Lule J
    Lancet; 1997 Aug; 350(9077):546-50. PubMed ID: 9284776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of Lactobacillus crispatus and L. vaginalis for vaginal health and the negative effect of recent sex: a cross-sectional descriptive study across groups of African women.
    Jespers V; van de Wijgert J; Cools P; Verhelst R; Verstraelen H; Delany-Moretlwe S; Mwaura M; Ndayisaba GF; Mandaliya K; Menten J; Hardy L; Crucitti T;
    BMC Infect Dis; 2015 Mar; 15():115. PubMed ID: 25879811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly diverse anaerobe-predominant vaginal microbiota among HIV-infected pregnant women in Zambia.
    Price JT; Vwalika B; Hobbs M; Nelson JAE; Stringer EM; Zou F; Rittenhouse KJ; Azcarate-Peril A; Kasaro MP; Stringer JSA
    PLoS One; 2019; 14(10):e0223128. PubMed ID: 31577818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal vaginal microbiota may be associated with poor reproductive outcomes: a prospective study in IVF patients.
    Haahr T; Jensen JS; Thomsen L; Duus L; Rygaard K; Humaidan P
    Hum Reprod; 2016 Apr; 31(4):795-803. PubMed ID: 26911864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial mismanagement: how inadequate treatments for vaginal dysbiosis drive the HIV epidemic in women.
    Gustin A; Cromarty R; Schifanella L; Klatt NR
    Semin Immunol; 2021 Jan; 51():101482. PubMed ID: 34120819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women.
    Klatt NR; Cheu R; Birse K; Zevin AS; Perner M; Noël-Romas L; Grobler A; Westmacott G; Xie IY; Butler J; Mansoor L; McKinnon LR; Passmore JS; Abdool Karim Q; Abdool Karim SS; Burgener AD
    Science; 2017 Jun; 356(6341):938-945. PubMed ID: 28572388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of the vaginal microbiota with HIV infection, bacterial vaginosis, and demographic factors.
    Chehoud C; Stieh DJ; Bailey AG; Laughlin AL; Allen SA; McCotter KL; Sherrill-Mix SA; Hope TJ; Bushman FD
    AIDS; 2017 Apr; 31(7):895-904. PubMed ID: 28121709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that the endometrial microbiota has an effect on implantation success or failure.
    Moreno I; Codoñer FM; Vilella F; Valbuena D; Martinez-Blanch JF; Jimenez-Almazán J; Alonso R; Alamá P; Remohí J; Pellicer A; Ramon D; Simon C
    Am J Obstet Gynecol; 2016 Dec; 215(6):684-703. PubMed ID: 27717732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of vaginal microbiome communities on HIV antiretroviral-based pre-exposure prophylaxis (PrEP) drug metabolism.
    Cheu RK; Gustin AT; Lee C; Schifanella L; Miller CJ; Ha A; Kim C; Rodriguez VJ; Fischl M; Burgener AD; Arnold KB; Alcaide ML; Klatt NR
    PLoS Pathog; 2020 Dec; 16(12):e1009024. PubMed ID: 33270801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diversity of vaginal microbiota in sub-Saharan Africa and its effects on HIV transmission and prevention.
    Bayigga L; Kateete DP; Anderson DJ; Sekikubo M; Nakanjako D
    Am J Obstet Gynecol; 2019 Feb; 220(2):155-166. PubMed ID: 30321529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The global health impact of vaginal dysbiosis.
    van de Wijgert JHHM; Jespers V
    Res Microbiol; 2017; 168(9-10):859-864. PubMed ID: 28257809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Influence of Cervicovaginal Microbiota on Mucosal Immunity and Prophylaxis in the Battle against HIV.
    Farcasanu M; Kwon DS
    Curr HIV/AIDS Rep; 2018 Feb; 15(1):30-38. PubMed ID: 29516267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human microbiome: implications for health and disease, including HIV infection.
    Schooley RT
    Top Antivir Med; 2018 Sep; 26(3):75-78. PubMed ID: 30384329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.